Zearalenone induces chromosome aberrations in mouse bone marrow: Preventive effect of 17β-estradiol, progesterone and Vitamin E

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 565, Issue 2, 2005, Pages 139-149

  Ouanes, Z ^a   Ayed Boussema, I ^a   Baati, T ^a   Creppy, E E ^b   Bacha, H ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

17 Estradiol; Chromosome aberrations; Progesterone; Vitamin E; Zearalenone

Indexed keywords

ALPHA TOCOPHEROL; ESTRADIOL; MYCOTOXIN; PROGESTERONE; ZEARALANONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CHROMOSOME ABERRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DRUG RECEPTOR BINDING; FEMALE; GENOTOXICITY; LD 50; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIOXIDANTS; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; CHROMOSOMES; ESTRADIOL; ESTROGENS, NON-STEROIDAL; FEMALE; MICE; MICE, INBRED BALB C; PROGESTERONE; RANDOM ALLOCATION; VITAMIN E; ZEARALENONE;

ANIMALIA;

EID: 12344305164     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2004.10.005     Document Type: Article

References (60)

1. P. Hidy, R. Baldwin, C. Greasham, C. Keith, and J. McMullen Zearalenone and some derivatives: production and biological activities Adv. Appl. Microbiol. 22 1977 55 82
2. T. Tanaka, A. Hasegawa, S. Yamamoto, U.S. Lee, Y. Sugiura, and Y. Ueno Worldwide contamination of cereals by the Fusarium mycotoxins, nivalenol, deoxynivalenol, and zearalenone 1. Survey of 19 countries J. Agric. Food Chem. 36 1988 979 983
3. IARC. Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins IARC IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans vol. 56 1993 IARC Lyon, France 397 444
4. C.J. Mirocha, P.V. Pathre, and T.S. Robinson Comparative metabolism of zearalenone and transmission into bovine milk Food Cosmet. Toxicol. 19 1981 25 30
5. D.W. Fitzpatrick, C.A. Picken, L.C. Murphy, and M.M. Buhr Measurement of the relative binding affinity of zearalenone, α-zearalenol and β-zearalenol for uterine and oviduct estrogen in swine, rats and chickens: an indicator of estrogenic potencies Comp. Biochem. Physiol. 2 1989 691 694
6. T. Kuiper-Goodman, P.M. Scoot, and H. Watanabe Risk assessment of the mycotoxin zearalenone Regul. Toxicol. Pharmacol. 7 1987 253 306
7. M.A. Diekman, and M.L. Green Mycotoxins and reproduction in domestic livestock J. Anim. Sci. 70 1992 1615 1627
8. B.S. Katzenellenbogen, J.A. Katzenellenbogen, and D. Mordecai Zearalenones: characterization of the estrogenic potencies and receptor interactions of a series of fungal β resorcylic acid lactones Endocrinology 105 1979 33 40
9. R.J. Miksicek Interaction of naturally occurring non steroidal estrogens with expressed recombinant human estrogen receptors J. Steroid Biochem. Mol. Biol. 49 1994 153-160
10. R. Le Guevel, and F. Pakdel Streamlined beta-galactosidase assay for analysis of recombinant yeast response to estrogens BioTechniques 30 5 2001 1000 1004
11. J. Matthews, T. Celius, R. Halgren, and T. Zachareweski Differential estrogen receptor binding of estrogenic substances: a species comparison J. Steroid Biochem. Mol. Biol. 74 2000 223 234
12. A. Breithofer, K. Graumann, M.S. Scicchitano, S.K. Karathanasis, T.R. Butt, and A. Jungbauer Regulation of human estrogen receptor by phytoestrogens in yeast and human cells J. Steroid Biochem. Mol. Biol. 67 1998 421 429
13. M.H. Kuczuk, P.M. Benson, H. Heath, and A.W. Hayes Evaluation of the mutagenic potential of mycotoxins using Salmonella typhimurium and Saccharomyces cerevisiae Mutat. Res. 53 1978 11 20
14. A. Stark Mutagenicity and carcinogenicity of mycotoxins: DNA binding as a possible mode of action Annu. Rev. Microbiol. 34 1980 235 262
15. R.W. Tennant, B.H. Margolin, M.D. Shelby, E. Zeiger, J.K. Haseman, J. Spalding, W. Caspan, M.A. Resnik, S. Staslewicz, B. Anderson, and R. Minor Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays Science 236 1987 933 941
16. G.M. Williams, H. Mori, and C.A. McQueen Structure-activity relationships in the rat hepatocyte DNA repair test for 300 chemicals Mutat. Res. 221 1989 263 286
17. A. Kasamaki, and S. Urasawa The effect of food chemicals on cell aging of human diploid cells in in vitro culture J. Toxicol. Sci. 18 1993 143 153
18. S.M. Galloway, M.J. Armstrong, C. Reuben, S. Colman, B. Brown, C. Cannon, A.D. Bloom, F. Nakamura, M. Ahmed, S. Duk, J. Rimpo, B.H. Margolin, M.A. Resnik, B. Anderson, and E. Zelger Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluations of 108 chemicals Environ. Mol. Mutagen. 10 1987 171 175
19. A. El Makawy, M.S. Hassanane, and E.A.M. Abd Alla Genotoxic evaluation for the estrogenic mycotoxin zearalenone Reprod. Nutr. Dev. 41 2001 79 89
20. M.B. Lioi, A. Santoro, R. Barbieri, S. Salzano, and M.V. Ursini Ochratoxin A and zearalenone: a comparative study on genotoxic effects and cell death in bovine lymphocytes Mutat. Res. 557 2004 19 27
21. R. Thurst, S. Kneist, and V. Huhne Genotoxicity of Fusarium mycotoxins (nivalenol, fusarenoe-X T2 toxin and zearalenone) in Chinese hamster V79-E cells in vitro Arch. Geschwulstforsch. 53 1983 9 15
22. Z. Ouanes, S. Abid, I. Ayed, R. Anane, T. Mobio, E.E. Creppy, and H. Bacha Induction of micronuclei by zearalenone in Vero monkey kidney cells and in bone marrow cells of mice: protective effect of Vitamin E Mutat. Res. 538 2003 63 70
23. S. Abid-Essefi, I. Baudrimont, W. Hassen, Z. Ouanes, T.A. Mobio, R. Anane, E.E. Creppy, and H. Bacha DNA fragmentation, apoptosis and cell cycle arrest induced by zearalenone in cultured DOK Vero and Caco-2 cells: prevention by Vitamin E Toxicology 192 2003 237 248
24. I.H. Kim, H.Y. Son, C.S. Ha, and B.H. Kang Zearalenone induces male germ cell apoptosis in rats Toxicol. Lett. 138 3 2003 185 192
25. National Toxicology Program (NTP), Carcinogenesis bioassay of zearalenone in F 344/N rats and B6C3F1 mice, Technical Report Series no. 235, Department of Health and Human Services, Research Triangle Park, NC, USA, 1982.
26. Y. Grosse, L. Chekir-Ghedira, A. Huc, S. Obrecht-Pflumio, G. Dirheimer, H. Bacha, and A. Pfohl-Leszkowicz Retinol, ascorbic acid and α-tocopherol prevent DNA adduct formation in mice treated with the mycotoxins ochratoxin A and zearalenone Cancer Lett. 114 1997 225 229
27. L. Ghedira-Chekir, K. Maaroufi, A. Zakhama, F. Ellouz, S. Dhouib, E.E. Creppy, and H. Bacha Induction of a SOS repair system in lysogenic bacteria by zearalenone and its prevention by Vitamin E Chem. Biol. lnteract. 113 1998 15 25
28. S. Abid-Essefi, Z. Ouanes, W. Hassen, I. Baudrimont, E. Creppy, and H. Bacha Cytotoxicity, inhibition DNA and protein syntheses and oxidative damage in cultured cells exposed to zearalenone Toxicol. In Vitro 18 2004 467 474
29. T.H. Yosida, and K. Amano Autosomal polymorphism in laboratory bred and wild Norway rats, Rattus norvegicus Chromosoma 16 1965 658 667
30. E.P. Evans, G. Breckon, and C.E. Ford An air drying method for meiotic preparation from mammalian tests Cytogenetics 3 1960 613 616
31. C.M. Placinta, J.P.F. D'mello, and A.M.C. MacDonald A review of worldwide contamination of cereal grains and animal feed with Fusarium mycotoxins Anim. Feed Sci. Technol. 78 1999 21 37
32. H.S. Hussein, and J.M. Brasel Toxicity, metabolism, and impact of mycotoxins on humans and animals Toxicology 167 2001 101 134
33. H. Bacha, L. Chekir, F. Ellouz, R. Hadidane, and E.E. Creppy Effect of zearalenone on fertilisation and gestation in rats K.A. Scudamore Proceedings of UK Workshop London 1993 258 262
34. W.F.O. Marasas, F.C. Wehner, S.J. Van Rensburg, and D.J. Van Schalkwyk Mycoflora of corn produced in human oesophageal cancer areas in Transkei, southern Africa Phytopatology 71 1981 792 795
35. J. Tomaszewski, R. Miturski, A. Semczuk, J. Kotarskl, and J. Jakowickl Tissue zearalenone concentration in normal, hyperplastic and neoplastic human endometrium Ginekol. Pol. 69 1998 363 366
36. L. Marin, J. Murtha, W. Dong, and J.J. Pestka Effects of mycotoxins on cytokine production and proliferation in EL4 thymoma cells J. Toxicol. Environ. Health 48 1996 379 396
37. M.F. Ruch, Y. Bi, L. Cox, D. Buk, A.C. Howlett, and C.J. Bellone Effect of environmental estrogens on IL1β promoter activity in a macrophage cell line Endocrinology 9 2 1998 207 211
38. H. Murata, N. Shimada, and M. Yashioka Suppressive effect of zearalenone, an estrogenic mycotoxin, on bovine neutrophil chemilluminescence Vit. Hum. Toxicol. 44 2 2002 83 86
39. K. Maaroufi, L. Chekir, E.E. Creppy, F. Ellouz, and H. Bacha Zearalenone induces modifications of haemotological and biochemical parameters in rats Toxicology 34 1996 535 540
40. E. Conkova, A. Laciakova, B. Pastorova, H. Seidel, and G. Kovac The effect of zearalenone on some enzymatic parameters in rabbits Toxicol. Lett. 121 2001 145 149
41. A. Pfohl-Leszkowicz, L. Chekir-Ghedira, and H. Bacha Genotoxicity of zearalenone, an estrogenic mycotoxin: DNA adducts formation in female mouse tissues Carcinogenesis 16 1995 2315 2320
42. Y. Luo, T. Yoshizawa, and T. Katayama Comparative study on the natural occurrence of Fusarium mycotoxins (trichothecenes and zearalenone) in corn and wheat from high and low-risk areas for human esophageal cancer in China Appl. Environ. Microbiol. 56 1990 3723 3726
43. J.A. Ruddick, M.P. Scott, and J. Harvig Teratological evaluation of zearalenone administered orally to the rat Bull. Environ. Contam. Toxicol. 15 1976 678 681
44. J.P. Becci, W.D. Johnson, F.G. Hess, M.A. Gallo, and R.A. Parent Combined two-generation reproduction-teratogenesis study of zearalenone in the rat J. Appl. Toxicol. 2 1982 201 206
45. M. Scheutwinkel, V.D.W. Hude, and A. Basler Studies on the genotoxicity of the anabolic drugs trenbolone and zeranol Arch. Toxicol. 59 1986 4 6
46. Y. Ueno, and K. Kubota DNA-attacking ability of carcinogenic mycotoxins in recombination-deficient mutant cells of Bacillus subtilis Cancer Res. 36 1976 445 451
47. M. Metzler, and E. Pffeifer Genotoxic potential of xenobiotic growth promoters and their metabolites APMIS 109 2 2001 89 95
48. W. Powell-Jones, S. Reaford, and G.W. Lucier Binding proprieties of zearalenone mycotoxins to hepatic estrogen receptors Mol. Pharmacol. 20 1981 35 42
49. D.L. Greenmann, R.G. Mehta, and J.L. Wittliff Nuclear interactions of Fusarium mucotoxins with β-estradiol binding sites in the mouse uterus J. Toxicol. Environ. Health 5 1979 593 598
50. P. Boyd, and J. Wittliff Mechanism of Fusarium mycotoxin action in mammary gland J. Toxicol. Environ. Health 4 1978 1 8
51. U. Mayer, A. Butsch, and S. Schneider Validation of two in vitro test systems for estrogenic activities with zearalenone, phytoestrogens and cereal extracts Toxicology 74 1992 135 149
52. W.T. Shier, A.C. Sier, W. Xie, and C.J. Mirocha Structure-activity relationships for human estrogenic activity in zearalenone mycotoxins Toxicon 39 2001 1435 1438
53. S. Ahamed, J.S. Foster, A. Bukovsky, and J. Wimalasena Signal transduction through the ras/Erk pathway is essential for the mycoestrogen zearalenone-induced cell cycle progression in MCF-7 cells Mol. Carcinogen. 30 2001 88 89
54. D.M. Sheehan, W.S. Branham, K.L. Medlock, and E.R.B. Shanmugasundaram Estrogenic activity of zearalenone and zearalnol in the neonatal uterus Teratology 29 1984 383 392
55. D.T. Kiang, B.J. Kennedy, S.V. Pathre, and C.J. Mirocha Binding characteristics of zearalenone analogs to estrogen receptors Cancer Res. 38 1978 3611 3615
56. V.M. Factor, D. Laskowska, M.R. Jensen, and J.T. Woitach Vitamin E reduces chromosome damage and inhibits hepatic tumor formation in a transgenic mouse model Proc. Natl. Acad. Sci. U.S.A. 97 2000 2196 2201
57. W.R. Bonorden, and M.W. Pariza Antioxidant nutrients and protection from free radicals Nutrition Toxicology 1994 Raven New York pp. 19-48
58. H. Sies, and W. Stahl Vitamins E and C, carotene, and other carotenoids as antioxidants Am. J. Clin. Nutr. 62 1995 1315 1321
59. M.G. Traber Vitamin E, nuclear receptors and xenobiotic metabolism Arch. Biochem. Biophys. 423 1 2004 6 11
60. N. Landes, M. Birringer, and R. Brigelius-Flohe Homologous metabolic and gene activating routes for Vitamins E and K Mol. Aspects Med. 24 6 2003 337 344